ESC 365 - New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Open Access

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Session: Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Topic: Atrial fibrillation (AF)

Speaker: Professor K. Fox (Edinburgh, GB)

Sponsored by Bayer AG

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

45 presentations

1 follower

4 more presentations in this session

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Professor R. Mehran (New York, US)

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Sesto San Giovanni, IT)

Access the full session

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Speakers: Professor K. Fox, Professor R. Mehran, Professor S. Hohnloser, Doctor C. Ruff, Doctor R. Cappato

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources